Etoperidone information

Etoperidone
Clinical data
Trade names	Several
Other names	ST-1191; McN-A-2673-11
Routes of; administration	By mouth
ATC code	N06AB09 (WHO) ;
Identifiers
	IUPAC name 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-4,5-diethyl-1,2,4-triazol-3-one;
CAS Number	52942-31-1 ;
PubChem CID	40589;
ChemSpider	37083 ;
UNII	KAI6MVO39Z;
ChEMBL	ChEMBL1743259 ;
CompTox Dashboard (EPA)	DTXSID0023034 ;
Chemical and physical data
Formula	C19H28ClN5O
Molar mass	377.92 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Clc3cccc(N2CCN(CCCN1/N=C(\N(C1=O)CC)CC)CC2)c3;
	InChI InChI=1S/C19H28ClN5O/c1-3-18-21-25(19(26)24(18)4-2)10-6-9-22-11-13-23(14-12-22)17-8-5-7-16(20)15-17/h5,7-8,15H,3-4,6,9-14H2,1-2H3 ; Key:IZBNNCFOBMGTQX-UHFFFAOYSA-N ;
	(what is this?) (verify)

Etoperidone, associated with several brand names, is an atypical antidepressant which was developed in the 1970s and either is no longer marketed or was never marketed.^[1]^[2]^[3] It is a phenylpiperazine related to trazodone and nefazodone in chemical structure and is a serotonin antagonist and reuptake inhibitor (SARI) similarly to them.^[4]

^ Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. p. 421. ISBN 978-3-88763-075-1.
^ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia. Elsevier. pp. 1533–. ISBN 978-0-8155-1856-3.
^ Akritopoulou-Zanze I (16 August 2012). "Arylpiperazine-Based 5-HT1A Receptor Partial Agonists and 5-HT2A Antagonists for the Treatment of Autism, Depression, Anxiety, Psychosis, and Schizophrenia". In Lamberth C, Dinges J (eds.). Bioactive Heterocyclic Compound Classes: Pharmaceuticals. John Wiley & Sons. pp. 81–97. doi:10.1002/9783527664450.ch6. ISBN 978-3-527-66447-4.
^ Morrison-Valfre M (23 August 2016). Foundations of Mental Health Care - E-Book. Elsevier Health Sciences. pp. 245–. ISBN 978-0-323-37104-9.

[IndexNominum2000-1] Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. p. 421. ISBN 978-3-88763-075-1.

[Publishing2013-2] William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia. Elsevier. pp. 1533–. ISBN 978-0-8155-1856-3.

[Akritopoulou-Zanze_2012-3] Akritopoulou-Zanze I (16 August 2012). "Arylpiperazine-Based 5-HT1A Receptor Partial Agonists and 5-HT2A Antagonists for the Treatment of Autism, Depression, Anxiety, Psychosis, and Schizophrenia". In Lamberth C, Dinges J (eds.). Bioactive Heterocyclic Compound Classes: Pharmaceuticals. John Wiley & Sons. pp. 81–97. doi:10.1002/9783527664450.ch6. ISBN 978-3-527-66447-4.

[Morrison-Valfre2016-4] Morrison-Valfre M (23 August 2016). Foundations of Mental Health Care - E-Book. Elsevier Health Sciences. pp. 245–. ISBN 978-0-323-37104-9.

Etoperidone information

and 27 Related for: Etoperidone information

Etoperidone

Phenylpiperazine

Trazodone

Mepiprazole

Serotonin antagonist and reuptake inhibitor

Cocaine

Lorpiprazole

List of antidepressants

ATC code N06

Rilmenidine

Sedative

Methaqualone

Insomnia

Buspirone

Adrenaline

MDMA

Duloxetine

Ketamine

Mirtazapine

LSD

Lemborexant

Monoamine oxidase inhibitor

Phencyclidine

C19H28ClN5O

Carvedilol

Pentobarbital

Dimenhydrinate